St. Jude Medical announces FDA approval and U.S. launch of AMPLATZER™ PFO Occluder
St. Jude Medical announced FDA approval and launch of the AMPLATZER™ PFO Occluder to help reduce the risk of recurrent ischemic strokes in patients diagnosed with a patent foramen ovale (PFO) – a small opening between the upper chambers of the heart. October 28, 2016